In the subsequent analysis, we examined the prognostic value of KLRB1 expression on CD8 T cells and NK cells within the low-risk subgroup of HCC patients (defined as AFP < 400 ng/mL, single tumor, tumor size < 5 cm and BCLC 0 + A). This evidence concerns the gene CD8A and neoplasm.